The Indian schizophrenia drug market is estimated to grow significantly at a CAGR of 4.0% during the forecast period. This growth is backed by the presence of a large pool of population with mental health disorder coupled with growing awareness towards mental health. In India, The Live Love Laugh Foundation (TLLLF) is a charity that intends to provide awareness regarding the mental disease and break the stigma associated with it, with a particular focus on depression, stress, and anxiety. Moreover, India has moderate resources for mental health, for instance, as per WHO, in India, the total number of mental health professionals including government and non-government were 25,312 in 2017. The number of psychiatrists per 100,000 population was 0.29 in 2017 in India. Along with that, India had 136 mental hospitals for inpatient care and 6.95 annual admissions per 100,000 population in mental hospitals in 2017, across various cities in India. These hospitals provide various services, therapies and treatment for mental healthcare disorders that further contribute to the growth of the market.

Visit for Global Schizophrenia Drugs Market Report at: https://www.omrglobal.com/industry-reports/schizophrenia-drugs-market

The Indian schizophrenia drug market is classified on the basis of therapeutic class and treatment. Based on therapeutic class, the market is segmented into second-generation antipsychotics, third-generation antipsychotics, and other therapeutic classes. Among these therapeutic classes, the second-generation antipsychotics are majorly used in therapeutic classes for the treatment of schizophrenia. Based on treatment, the market is bifurcated into oral and injectables. The oral treatment solution dominates the market due to the presence of a large number of drug manufacturing companies in the country.

The companies which are contributing to the growth of the India schizophrenia drugs market include Allergan PLC, Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Co., AstraZeneca PLC, and Johnson & Johnson Services, Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. 

Research Methodology

The market study of the Indian schizophrenia drug market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.

Market Segmentation

1. Indian Schizophrenia Drugs Market Research and Analysis by Therapeutic Class
2. Indian Schizophrenia Drugs Market Research and Analysis by Treatment

The Report Covers

• Comprehensive research methodology of the Indian schizophrenia drug market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Indian schizophrenia drug market.
• Insights about market determinants which are stimulating the Indian schizophrenia drug market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.